ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05200	Pathways in cancer	43/151	492/7206	1.44030862879e-16
ko04390	Hippo signaling pathway	25/151	188/7206	7.23437602946e-14
ko05217	Basal cell carcinoma	16/151	68/7206	3.5811227519e-13
ko04360	Axon guidance	26/151	233/7206	1.44499299289e-12
ko04550	Signaling pathways regulating pluripotency of stem cells	19/151	165/7206	1.14198515456e-09
ko05224	Breast cancer	19/151	174/7206	2.82732485987e-09
ko04310	Wnt signaling pathway	18/151	181/7206	3.36298221128e-08
ko05205	Proteoglycans in cancer	21/151	271/7206	1.7845313777e-07
ko05206	MicroRNAs in cancer	16/151	177/7206	7.60090669995e-07
ko04916	Melanogenesis	14/151	142/7206	1.37334975041e-06
ko04151	PI3K-Akt signaling pathway	24/151	390/7206	1.56797749354e-06
ko04391	Hippo signaling pathway - fly	11/151	90/7206	2.38405299152e-06
ko04392	Hippo signaling pathway -multiple species	7/151	31/7206	2.66169848785e-06
ko04340	Hedgehog signaling pathway	9/151	58/7206	2.72150170411e-06
ko05166	HTLV-I infection	19/151	292/7206	9.7474125845e-06
ko05222	Small cell lung cancer	10/151	89/7206	1.49222008922e-05
ko04150	mTOR signaling pathway	14/151	184/7206	2.82949756943e-05
ko05212	Pancreatic cancer	9/151	83/7206	5.37863652797e-05
ko04350	TGF-beta signaling pathway	10/151	103/7206	5.38813446701e-05
ko04520	Adherens junction	10/151	103/7206	5.38813446701e-05
ko05220	Chronic myeloid leukemia	9/151	85/7206	6.50169793959e-05
ko04933	AGE-RAGE signaling pathway in diabetic complications	11/151	135/7206	0.000114275841235
ko04014	Ras signaling pathway	16/151	279/7206	0.000227804787145
ko04512	ECM-receptor interaction	8/151	79/7206	0.000228782075425
ko05161	Hepatitis B	12/151	173/7206	0.000258588985693
ko04015	Rap1 signaling pathway	15/151	278/7206	0.00068492565657
ko04024	cAMP signaling pathway	15/151	279/7206	0.000710898433245
ko04330	Notch signaling pathway	6/151	62/7206	0.00179193240318
ko05215	Prostate cancer	8/151	111/7206	0.00220431571159
ko04919	Thyroid hormone signaling pathway	9/151	143/7206	0.00300734715437
ko04510	Focal adhesion	12/151	240/7206	0.00441125954781
ko05152	Tuberculosis	10/151	187/7206	0.00576505658415
ko04659	Th17 cell differentiation	7/151	106/7206	0.00666778384216
ko04530	Tight junction	11/151	228/7206	0.00821621978042
ko04068	FoxO signaling pathway	9/151	167/7206	0.0082627020824
ko05210	Colorectal cancer	6/151	86/7206	0.00909972026813
ko05223	Non-small cell lung cancer	5/151	66/7206	0.0121161526052
ko04080	Neuroactive ligand-receptor interaction	2/151	423/7206	0.0126282539139
ko04066	HIF-1 signaling pathway	7/151	123/7206	0.0144975305687
ko04658	Th1 and Th2 cell differentiation	6/151	96/7206	0.015144695279
ko05145	Toxoplasmosis	7/151	126/7206	0.0163679880862
ko05146	Amoebiasis	6/151	99/7206	0.0174000352981
ko05219	Bladder cancer	4/151	48/7206	0.0176524689316
ko04370	VEGF signaling pathway	5/151	77/7206	0.0223305500846
ko04931	Insulin resistance	7/151	137/7206	0.0246922517288
ko05230	Central carbon metabolism in cancer	5/151	81/7206	0.0271113131224
ko05321	Inflammatory bowel disease (IBD)	4/151	56/7206	0.0293280148347
ko04218	Cellular senescence	8/151	177/7206	0.0321774432892
ko04110	Cell cycle	7/151	145/7206	0.0323231178321
ko04668	TNF signaling pathway	6/151	120/7206	0.0398391792067
ko05221	Acute myeloid leukemia	4/151	63/7206	0.0425644335408
ko04211	Longevity regulating pathway	6/151	123/7206	0.0440774244489
ko04341	Hedgehog signaling pathway - fly	3/151	38/7206	0.0446049875903
ko04640	Hematopoietic cell lineage	4/151	64/7206	0.0446896800519
ko01522	Endocrine resistance	6/151	124/7206	0.0455506963582